{"id":184466,"date":"2012-04-21T20:09:00","date_gmt":"2012-04-22T01:09:00","guid":{"rendered":"https:\/\/www.panix.com\/~msaroff\/40years\/2012\/04\/21\/good-patent-news-everyone\/"},"modified":"2012-04-21T20:09:00","modified_gmt":"2012-04-22T01:09:00","slug":"good-patent-news-everyone","status":"publish","type":"post","link":"https:\/\/www.panix.com\/~msaroff\/40years\/2012\/04\/21\/good-patent-news-everyone\/","title":{"rendered":"Good Patent News Everyone"},"content":{"rendered":"<p>For once, the <a href=\"http:\/\/www.rawstory.com\/rs\/2012\/04\/18\/supreme-court-ruling-supports-generic-drug-makers\/\">generic drug manufacturers win one<\/a>:<\/p>\n<blockquote style=\"color: blue;\"><p>The US Supreme Court ruled that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.<\/p>\n<p>The measure overturns a 2010 appeals court ruling and confirms an earlier decision by a federal judge that ordered the US subsidiary of Danish laboratory Novo Nordisk to narrow the description of its patent on repaglinide, an anti-diabetes drug sold under the name Prandin.<\/p>\n<p>Caraco Pharmaceutical Laboratories, the US subsidiary of the Indian firm Sun Pharmaceutical Industries, is seeking to produce a generic version of Prandin.<\/p>\n<p>However Novo Nordisk amended the wording of his patent to extend it, and block the Caraco\u2019s request to the US Food and Drug Administration (FDA) to produce a generic version of the drug.<\/p>\n<p>The FDA cannot approve the sale of a drug that breaks patent protection laws.<\/p>\n<p>In a unanimous decision by the nine Supreme Court justices on Tuesday, Justice Elena Kagan wrote that \u201ca generic company can employ the counterclaim to challenge a brand\u2019s overbrand use code.\u201d<\/p><\/blockquote>\n<p>Courts have gotten much more skeptical of what I call overbroad patent bullsh%$ over the years, so this is more of&nbsp; a good trend.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For once, the generic drug manufacturers win one: The US Supreme Court ruled that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions. The measure overturns a 2010 appeals court ruling and confirms an earlier decision by a federal judge that ordered the &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1109,972,1074],"tags":[],"class_list":["post-184466","post","type-post","status-publish","format-standard","hentry","category-ip","category-justice","category-medical"],"_links":{"self":[{"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/posts\/184466"}],"collection":[{"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/comments?post=184466"}],"version-history":[{"count":0,"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/posts\/184466\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/media?parent=184466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/categories?post=184466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.panix.com\/~msaroff\/40years\/wp-json\/wp\/v2\/tags?post=184466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}